TY - JOUR
T1 - Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics
AU - Tomoshige, Shusuke
AU - Dik, David A.
AU - Akabane-Nakata, Masaaki
AU - Madukoma, Chinedu S.
AU - Fisher, Jed F.
AU - Shrout, Joshua D.
AU - Mobashery, Shahriar
N1 - Funding Information:
This work was supported by grants GM61629 (S.M.) and AI113219 (J.D.S.) from the NIH. S.T. was supported by a postdoctoral fellowship from the Uehara Memorial Foundation. D.A.D. was supported by NIH Training Grant T32GM075762 and by the ECK Institute for Global Health.
Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/6/8
Y1 - 2018/6/8
N2 - The bulgecins are iminosaccharide secondary metabolites of the Gram-negative bacterium Paraburkholderia acidophila and inhibitors of lytic transglycosylases of bacterial cell-wall biosynthesis and remodeling. The activities of the bulgecins are intimately intertwined with the mechanism of a cobiosynthesized β-lactam antibiotic. β-Lactams inhibit the penicillin-binding proteins, enzymes also critical to cell-wall biosynthesis. The simultaneous loss of the lytic transglycosylase (by bulgecin) and penicillin-binding protein (by β-lactams) activities results in deformation of the septal cell wall, observed microscopically as a bulge preceding bacterial cell lysis. We describe a practical synthesis of the three naturally occurring bulgecin iminosaccharides and their mechanistic evaluation in a series of microbiological studies. These studies identify potentiation by the bulgecin at subminimum inhibitory concentrations of the β-lactam against three pathogenic Gram-negative bacteria and establish for the first time that this potentiation results in a significant increase in the bactericidal efficacy of a clinical β-lactam.
AB - The bulgecins are iminosaccharide secondary metabolites of the Gram-negative bacterium Paraburkholderia acidophila and inhibitors of lytic transglycosylases of bacterial cell-wall biosynthesis and remodeling. The activities of the bulgecins are intimately intertwined with the mechanism of a cobiosynthesized β-lactam antibiotic. β-Lactams inhibit the penicillin-binding proteins, enzymes also critical to cell-wall biosynthesis. The simultaneous loss of the lytic transglycosylase (by bulgecin) and penicillin-binding protein (by β-lactams) activities results in deformation of the septal cell wall, observed microscopically as a bulge preceding bacterial cell lysis. We describe a practical synthesis of the three naturally occurring bulgecin iminosaccharides and their mechanistic evaluation in a series of microbiological studies. These studies identify potentiation by the bulgecin at subminimum inhibitory concentrations of the β-lactam against three pathogenic Gram-negative bacteria and establish for the first time that this potentiation results in a significant increase in the bactericidal efficacy of a clinical β-lactam.
KW - antibiotic resistance
KW - bacteria
KW - cell wall
KW - lytic transglycosylases
KW - β-lactam antibiotics
UR - http://www.scopus.com/inward/record.url?scp=85046623419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046623419&partnerID=8YFLogxK
U2 - 10.1021/acsinfecdis.8b00105
DO - 10.1021/acsinfecdis.8b00105
M3 - Article
C2 - 29716193
AN - SCOPUS:85046623419
SN - 2373-8227
VL - 4
SP - 860
EP - 867
JO - ACS Infectious Diseases
JF - ACS Infectious Diseases
IS - 6
ER -